Founded in 2014 by orthopedic surgeon Steven Goldberg, MD, Catalyst has set ourselves apart with an unwavering dedication to make shoulder replacements less invasive, with fewer complications and a more natural-feeling shoulder after surgery. Whether through total shoulder replacements, reverse shoulder arthroplasty, or other innovative procedures, we strive to advance techniques and devices for orthopedic surgery to maximize outcomes for patients, surgeons and the broader healthcare system.
PURPOSEFULLY DESIGNED™
We’re advancing the world of shoulder arthroplasty.
Experience what sets us apart.
DR. STEVEN GOLDBERG
OUR VISION
To be the best pure play shoulder company that sets new standards in shoulder surgery.
OUR MISSION
To design innovative products and solutions that continually improve shoulder replacement outcomes.
- Products based on years of proven research and clinical experience
- Precise and consistent implant placement
- Streamlined surgical techniques
- Maximal preservation of healthy tissues
- New standards in efficiencies for all parties involved
OUR QUALITY POLICY
Our pledge at Catalyst OrthoScience is to deliver the highest quality medical devices that will meet or exceed the expectations of our customers, meet regulatory requirements and demonstrate our commitment to excellence.
As part of this commitment, Catalyst OrthoScience will strive to continually improve the safety and efficacy of our products through an effective quality management system.
JOIN THE TEAM
If you’re ready to help us lead the evolution of shoulder arthroplasty, we’re ready for you.
SEE OPEN POSITIONS
NEWS
Catalyst OrthoScience Announces FDA 510(k) Clearance for Shoulder Fracture System and First Cases
NAPLES, Fla., - Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announces it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the first surgeries have been successfully performed for the Catalyst Fracture…
Read More
Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing
NAPLES, Fla., – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announces it has surpassed 10,000 total shoulder arthroplasty (TSA) procedures as it closes $20 million in equity and venture debt financing with funding partners RC Capital,…
Read More
Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer
NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D. as chief strategy officer of the organization, effective immediately. “The board and I are excited to have an executive with Dr. Ables’ experience and leadership join our team…
Read More
1000-0002-A
